TASKIN Company Profile

DestroCell

news-2850

Taskin Support for the Specialized Symposium on "Oncolytic Virus Engineering for Cancer Treatment"

On April 21, 2025, a specialized symposium titled “Oncolytic Virus Engineering for Cancer Treatment”...
Read More
news-2841

Taskin at the 14th Hematopoietic Stem Cell Transplantation Congress & 1st National Hematology Congress 2025

Taskin BioRegeneration, as one of the pioneers in the field of cell therapy, had an active and impactful...
Read More
news-2832

Taskin BioRegeneration proudly sponsored and participated in the 4th IranBio International Congress and Exhibition 2025

Taskin BioRegeneration actively participated as one of the sponsors of the 4th IranBio International...
Read More
RYONCIL-FDA-1

FDA Approves First MSC Therapy for SR-aGVHD: A Milestone in Cell Therapy

The U.S. Food and Drug Administration (FDA) has announced the historic approval of Ryoncil (remestemcel-L-rknd)...
Read More

Job Opportunity – Researcher Positions at Taskin Bioregeneration

Taskin Bioregeneration is a leading company in the field of cell and gene therapy. We are currently conducting clinical trials focused on innovative treatments that harness the power of regenerative medicine.

About Us

At Taskin Bioregeneration, we are pioneers in revolutionizing healthcare through cutting-edge advancements in cell and gene therapy. With a rich history deeply rooted in the medical landscape of Iran, our journey began with the inception of Taskin Hospital in Rafsanjan, supported by charitable endeavors.

Pipe Line

At Taskin Bioregeneration, our dedication to pioneering cell and gene therapies drives us to push the boundaries of medical science. Our pipeline showcases a range of innovative therapies, each aimed at addressing critical health conditions. Here’s a closer look at our current projects

Scroll to Top